Mode
Text Size
Log in / Sign up

enalapril

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of enalapril

21 trials tracked of enalapril: 19 in phase 3 or 4 and 8 with published results. The most-cited published study has 319 citations.

21Trials tracked
19Phase 3 & 4
0Recruiting
8With published results
Phase distribution
Phase 4 7 Phase 3 12 Phase 2 1 Other / NA 1
  1. Phase 4 Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction Completed · 319 cited
  2. Phase 3 A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients Completed · 157 cited
  3. Phase 4 Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode. Completed · 87 cited
  4. Phase 3 Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure Completed · 46 cited
  5. Phase 3 Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure Completed · 40 cited
  6. Phase 4 Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients. Completed · 31 cited
Show 15 more trials
  1. Phase 4 Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC Completed · 14 cited
  2. Phase 4 Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period Completed · 8 cited
  3. Phase 4 Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction. Completed
  4. Phase 4 Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone Completed
  5. Phase 3 randOmized stUdy Using acceleromeTry to Compare Sacubitril/valsarTan and Enalapril in Patients With Heart Failure Completed
  6. Phase 3 Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction Completed
  7. Phase 3 COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart Failure Completed
  8. Phase 3 An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age Completed
  9. Phase 3 A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011) Completed
  10. Phase 3 An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2)) Completed
  11. Phase 3 Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension Completed
  12. Phase 3 Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure Completed
  13. Phase 3 Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart Network Completed
  14. Phase 2 Mitigation of Radiation Pneumonitis and Fibrosis Completed
  15. N/A Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer Completed

Showing the 21 most-cited and recently-updated of 21 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.